Correction: Association between oxygen saturation targeting and death or disability in extremely preterm infants in the neonatal oxygenation prospectivemeta-analysis collaboration (JAMA - Journal of the American Medical Association (2018) 319:21 (2190-2201) DOI: 10.1001/jama.2018.5725);Association between oxygen saturation targeting and death or disability in extremely preterm infants in the neonatal oxygenation prospective meta-analysis collaboration

JAMA - Journal of the American Medical Association

Volumn 319, Issue 21, 2018, Pages 2190-2201

  Askie, Lisa M ^a   Darlow, Brian A ^b   Finer, Neil ^c   Schmidt, Barbara ^d,e   Stenson, Ben ^f   Tarnow Mordi, William ^a   Davis, Peter G ^g,h   Carlo, Waldemar A ⁱ   Brocklehurst, Peter ^j,k   Davies, Lucy C ^a   Das, Abhik ^l   Rich, Wade ^c   Gantz, Marie G ^l   Roberts, Robin S ^e   Whyte, Robin K ^m   Costantini, Lorrie ^e   Poets, Christian ⁿ   Asztalos, Elizabeth ^o   Battin, Malcolm ^p   Halliday, Henry L ^q,r   Marlow, Neil ^v   Tin, Win ^t   King, Andrew ^k   Juszczak, Edmund ^k   Morley, Colin J ^s,u   Doyle, Lex W ^g,h   Gebski, Val ^a   Hunter, Kylie E ^a   Simes, Robert J ^a   more..

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e MCMASTER UNIVERSITY   (Canada)

^f ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^g UNIVERSITY OF MELBOURNE   (Australia)

^h MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

ⁱ University of Alabama at Birmingham   (United States)

^j UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^k UNIVERSITY OF OXFORD   (United Kingdom)

^l RTI INTERNATIONAL   (United States)

^m DALHOUSIE UNIVERSITY   (Canada)

ⁿ UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^o UNIVERSITY OF TORONTO   (Canada)

^p AUCKLAND CITY HOSPITAL   (New Zealand)

^q ROYAL MATERNITY HOSPITAL   (United Kingdom)

^r QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^s UNIVERSITY COLLEGE LONDON   (United Kingdom)

^t JAMES COOK UNIVERSITY   (Australia)

^u UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^v NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; OXYGEN;

ARTICLE; ATTRIBUTABLE RISK; BAYLEY SCALES OF INFANT DEVELOPMENT; BIRTH WEIGHT; CESAREAN SECTION; CLINICAL OUTCOME; COGNITION; COGNITIVE DEFECT; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DEATH; DISABILITY; DISEASE SEVERITY; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; LANGUAGE; LIGATION; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MORBIDITY; MULTIPLE PREGNANCY; NECROTIZING ENTEROCOLITIS; OXYGEN SATURATION; OXYGEN THERAPY; OXYGENATION; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PRENATAL CARE; PROSPECTIVE STUDY; PULSE OXIMETRY; RANDOMIZED CONTROLLED TRIAL; RETROLENTAL FIBROPLASIA; RISK ASSESSMENT; SMALL FOR DATE INFANT; BLINDNESS; BLOOD; CEREBRAL PALSY; COMPARATIVE STUDY; DEVELOPMENTAL DISORDER; HEARING IMPAIRMENT; INCIDENCE; INFANT MORTALITY; KAPLAN MEIER METHOD; MORTALITY; NEWBORN; OXIMETRY; RANDOMIZED CONTROLLED TRIAL (TOPIC);

BLINDNESS; CEREBRAL PALSY; DEAFNESS; DEVELOPMENTAL DISABILITIES; ENTEROCOLITIS, NECROTIZING; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT MORTALITY; INFANT, EXTREMELY PREMATURE; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; KAPLAN-MEIER ESTIMATE; MALE; OXIMETRY; OXYGEN; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85048270550     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2018.9635     Document Type: Erratum

References (42)

1. Askie LM, Henderson-Smart DJ. Restricted versus liberal oxygen exposure for preventing morbidity and mortality in preterm or low birth weight infants. Cochrane Database Syst Rev. 2001;4(4):CD001077.
2. Hellström A, Smith LE, Dammann O. Retinopathy of prematurity. Lancet. 2013;382 (9902):1445-1457.
3. Tin W, Milligan DW, Pennefather P, Hey E. Pulse oximetry, severe retinopathy, and outcome at one year in babies of less than 28 weeks gestation. Arch Dis Child Fetal Neonatal Ed. 2001;84(2):F106-F110.
4. STOP-ROP Investigators. Supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP), a randomized, controlled trial, I: primary outcomes. Pediatrics. 2000;105 (2):295-310.
5. Askie LM, Henderson-Smart DJ, Irwig L, Simpson JM. Oxygen-saturation targets and outcomes in extremely preterm infants. N Engl J Med. 2003;349(10):959-967.
6. Cole CH, Wright KW, Tarnow-Mordi W, Phelps DL; Pulse Oximetry Saturation Trial for Prevention of Retinopathy of Prematurity Planning Study Group. Resolving our uncertainty about oxygen therapy. Pediatrics. 2003;112(6 pt 1):1415-1419.
7. Askie LM, Darlow BA, Davis PG, et al. Effects of targeting lower versus higher arterial oxygen saturations on death or disability in preterm infants. Cochrane Database Syst Rev. 2017;4:CD011190.
8. Clinical Trials website. Surfactant Positive Airway Pressure and Pulse Oximetry Trial (SUPPORT). https://clinicaltrials.gov/ct2/show/NCT00233324. Accessed March 12, 2018.
9. Current Controlled Trials website. Efficacy and safety of targeting lower arterial oxygen saturations to reduce oxygen toxicity and oxidative stress in very preterm infants: the Canadian Oxygen Trial. http://www.isrctn.com/ISRCTN62491227. Accessed March 12, 2018.
10. Australian New Zealand Clinical Trials Registry website. A randomised phase III study to evaluate whether a lower versus a higher oxygen saturation target in infants of <28 weeks gestation is associated with a reduction in death or disability at 2 years of age. http://www.anzctr.org.au/ACTRN12605000253606.aspx. Accessed March 12, 2018.
11. Current Controlled Trials website. Which oxygen saturation level should we use for very premature infants? a randomised controlled trial. http://www.isrctn.com/ISRCTN00842661. Accessed March 12, 2018.
12. Australian New Zealand Clinical Trials Registry website. Which oxygen saturation level should we use for very premature infants? a randomised controlled trial to investigate the effect of two slightly different oxygen levels on the health of very premature infants. http://www.anzctr.org.au/ACTRN12605000055606.aspx. Accessed March 12, 2018.
13. Ghersi D, Berlin J, Askie L. Prospective meta-analysis. In: Cochrane Handbook for Systematic Reviews of Interventions: vol 5.1.0; 2011. http://www.handbook.cochrane.org. Accessed May 10, 2018.
14. Askie LM, Brocklehurst P, Darlow BA, Finer N, Schmidt B, Tarnow-Mordi W; NeOProM Collaborative Group. NeOProM: Neonatal Oxygenation Prospective Meta-analysis Collaboration study protocol. BMC Pediatr. 2011;11 (6):6.
15. Carlo WA, Finer NN, Walsh MC, et al; SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network. Target ranges of oxygen saturation in extremely preterm infants. N Engl J Med. 2010;362(21):1959-1969.
16. Vaucher YE, Peralta-Carcelen M, Finer NN, et al; SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network. Neurodevelopmental outcomes in the early CPAP and pulse oximetry trial. N Engl J Med. 2012;367 (26):2495-2504.
17. Schmidt B, Whyte RK, Asztalos EV, et al; Canadian Oxygen Trial (COT) Group. Effects of targeting higher vs lower arterial oxygen saturations on death or disability in extremely preterm infants: a randomized clinical trial. JAMA. 2013;309(20):2111-2120.
18. Darlow BA, Marschner SL, Donoghoe M, et al; Benefits Of Oxygen Saturation Targeting-New Zealand (BOOST-NZ) Collaborative Group. Randomized controlled trial of oxygen saturation targets in very preterm infants: two year outcomes. J Pediatr. 2014;165(1):30-35.e2.
19. Stenson BJ, Tarnow-Mordi WO, Darlow BA, et al; BOOST II United Kingdom Collaborative Group; BOOST II Australia Collaborative Group; BOOST II New Zealand Collaborative Group. Oxygen saturation and outcomes in preterm infants. N Engl J Med. 2013;368(22):2094-2104.
20. Tarnow-Mordi W, Stenson B, Kirby A, et al; BOOST-II Australia and United Kingdom Collaborative Groups. Outcomes of two trials of oxygen-saturation targets in preterm infants. N Engl J Med. 2016;374(8):749-760.
21. Johnston ED, Boyle B, Juszczak E, King A, Brocklehurst P, Stenson BJ. Oxygen targeting in preterm infants using the Masimo SET radical pulse oximeter. Arch Dis Child Fetal Neonatal Ed. 2011;96 (6):F429-F433.
22. Stenson B, Brocklehurst P, Tarnow-Mordi W; UK BOOST II trial; Australian BOOST II trial; New Zealand BOOST II trial. Increased 36-week survival with high oxygen saturation target in extremely preterm infants. N Engl J Med. 2011;364 (17):1680-1682.
23. Bayley N. Bayley Scales of Infant and Toddler Development. 3rd ed. San Antonio, TX: Harcourt Assessment Inc; 2006.
24. Palisano RJ, Hanna SE, Rosenbaum PL, et al. Validation of a model of gross motor function for children with cerebral palsy. Phys Ther. 2000;80 (10):974-985.
25. Higgins JPT, Altman DG, Sterne JAC; Cochrane Statistical Methods Group; Cochrane Bias Methods Group. Assessing risk of bias in included studies. In: Cochrane Handbook for Systematic Reviews of Interventions: vol 5.1.0; 2011. http://www.handbook.cochrane.org. Accessed May 10, 2018.
26. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557-560.
27. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53(282):457-481.
28. Kramer MS, Platt RW, Wen SW, et al; Fetal/Infant Health Study Group of the Canadian Perinatal Surveillance System. A new and improved population-based Canadian reference for birth weight for gestational age. Pediatrics. 2001;108(2): E35.
29. Alexander GR, Himes JH, Kaufman RB, Mor J, Kogan M. A United States national reference for fetal growth. Obstet Gynecol. 1996;87(2):163-168.
30. Walsh MC, Di Fiore JM, Martin RJ, Gantz M, Carlo WA, Finer N. Association of oxygen target and growth status with increased mortality in small for gestational age infants: further analysis of the Surfactant, Positive Pressure and Pulse Oximetry Randomized Trial. JAMA Pediatr. 2016;170(3):292-294.
31. Wang R, Lagakos SW, Ware JH, Hunter DJ, Drazen JM. Statistics in medicine—reporting of subgroup analyses in clinical trials. N Engl J Med. 2007;357(21):2189-2194.
32. Rich W, Finer NN, Gantz MG, et al; SUPPORT and Generic Database Subcommittees of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Enrollment of extremely low birth weight infants in a clinical research study may not be representative. Pediatrics. 2012;129(3):480-484.
33. Stenson BJ. Oxygen targets for preterm infants. Neonatology. 2013;103(4):341-345.
34. Schmidt B, Roberts RS, Whyte RK, et al; Canadian Oxygen Trial Group. Impact of study oximeter masking algorithm on titration of oxygen therapy in the Canadian oxygen trial. J Pediatr. 2014;165(4):666-71.e2.
35. Cummings JJ, Lakshminrusimha S, Polin RA. Oxygen-saturation targets in preterm infants. N Engl J Med. 2016;375(2):186-187.
36. Whyte RK, Nelson H, Roberts RS, Schmidt B. Benefits of oxygen saturation targeting trials: oximeter calibration software revision and infant saturations. J Pediatr. 2017;182:382-384.
37. Simes RJ; PPP and CTT Investigators. Prospective meta-analysis of cholesterol-lowering studies: the Prospective Pravastatin Pooling (PPP) Project and the Cholesterol Treatment Trialists (CTT) Collaboration. Am J Cardiol. 1995;76(9):122C-126C.
38. Ioannidis J. Next-generation systematic reviews: prospective meta-analysis, individual-level data, networks and umbrella reviews. Br J Sports Med. 2017;51(20):1456-1458.
39. Cummings JJ, Polin RA; Committee on Fetus and Newborn. Oxygen targeting in extremely low birth weight infants. Pediatrics. 2016;138(2): e20161576.
40. Schmidt B, Whyte RK, Roberts RS. Trade-off between lower or higher oxygen saturations for extremely preterm infants: the first benefits of oxygen saturation targeting (BOOST) II trial reports its primary outcome. J Pediatr. 2014;165(1):6-8.
41. Bassler D, Briel M, Montori VM, et al; STOPIT-2 Study Group. Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis. JAMA. 2010;303(12):1180-1187.
42. Schou IM, Marschner IC. Meta-analysis of clinical trials with early stopping: an investigation of potential bias. Stat Med. 2013;32(28):4859-4874.